Shows
KAP • Kunst, Kultur, Architektur, Wissenschaft, Forschung.#100 Salz des Lebens! Über Kalium und die bahnbrechende Technologie des Start-up elyte diagnostics. Mit Prof. Dr. Julia Mader, DI Dr. Andreas Fercher, DI Dr. Stefan Köstler.Für unsere Jubiläumsfolge, die 100 ste Folge von KAP Podcast sind wir nach Graz gereist und treffen an der MedUni ein multidisziplinäres Forscher Team. Heute geht’s um etwas, das viele gar nicht auf dem Schirm haben – aber lebenswichtig ist: Kalium und um eine revolutionäre und bahnbrechende Technologie. Mit dem Gründer Team von elyte diagnosics, Prof. Dr. Julia Mader, DI Dr. Andreas Fercher und DI Dr. Stefan Köstler, tauchen wir ein in die faszinierende Welt der Medizintechnik. Birgit Eller Krumm ist Kapitän dieser spannenden Folge.
Links zur Folge:
Homepage: www.elytedia...2025-08-1048 min
SBDN364 - Cobertura EASD - resumo 10/09 – Fernando Valente e Marcio KrakauerN364 - Cobertura EASD - resumo 10/09 – Fernando Valente e Marcio Krakauer by SBD2025-07-1116 min
Diabetes Insights - Breakthroughs and InnovatorsThe Future of Diabetes Technology: Beyond Devices to Equity and Personalisation
Watch the full video on YouTube to explore how technology is transforming diabetes care.
In this episode, our host Vivienne Parry is joined by Anna Krook (Karolinska Institute), Klemen Dovč (Ljubljana University Medical Centre), Peter Gillard (University Hospital Leuven), and Julia Mader (University of Graz) to discuss:
Advances in continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems
How AI and data integration are shaping diabetes management
Personalisation trends from sensors tailored to skin types and ages to systems addressing exercise and pregnancy
The importance of device performance standards and regulatory oversight
Why equity, access, a...2025-07-0411 min
Diabetes Insights - Breakthroughs and InnovatorsCan Pre-Diabetes Remission Reduce Global Diabetes Incidences?
Watch the full video on YouTube to learn how pre-diabetes remission could reshape diabetes care and prevention strategies globally. In this episode, Dr Andreas Birkenfeld (Germany) and Dr. Viswanathan Mohan (India) join Vivienne Parry to discuss:
The clinical case for pre-diabetes remission
How opportunistic and risk-based screening can improve outcomes
The economic case for early intervention in diabetes care
Policy barriers and the need for tailored national strategies
How awareness and advocacy can shift the public and political conversation
Learn more about our speakers and their work:
Dr Andreas Birkenfeld
Dr. Viswanathan Mohan
2025-06-2711 min
Diabetes Insights - Breakthroughs and InnovatorsWhat Will the Future Bring for People Living with Diabetes?
In this episode, diabetes advocates Bastian Hauck, Renza Scibilia and Christian Collin join Vivienne Parry to discuss recent advances in diabetes prevention, screening, and therapeutics - from GLP-1 drugs to innovative community-driven screening strategies. But as science accelerates, can our health systems and societies keep up?
The conversation covers:
Prevention strategies and screening
Stigma and advocacy differences between type 1 and type 2 diabetes
Disparities in access to therapies within societies and globally
Role of people living with diabetes in driving access and innovation
The importance of community engagement in education and policy change
2025-06-2019 min
SBDN344 - Cobertura EASD - Resumo 09/09 - Marcio Krakauer e Fernando ValenteN344 - Cobertura EASD - Resumo 09/09 - Marcio Krakauer e Fernando Valente by SBD2025-06-1712 min
Diabetes Insights - Breakthroughs and InnovatorsWill Next Generation Obesity Drugs make Bariatric Surgery Obsolete?
Watch the full debate to hear two leading experts tackle one of the most talked-about questions in obesity care. In this episode, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Cornell Medical College) join Vivienne Parry to debate whether next-generation medications will eventually make obesity surgery obsolete.
The conversation covers:
•The evolving role of bariatric surgery in an era of powerful GLP-1-based therapies
•What new medications and minimally invasive procedures could reshape obesity care
•The economic, clinical, and patient-preference factors influencing treatment choices
•Why obesity management is moving toward multi-modal, integrated care models
•The importan...2025-06-1311 min
Diabetes Insights - Breakthroughs and InnovatorsBreaking Barriers: Public-Private Partnerships Revolutionizing Diabetes Research
Watch the full video on YouTube to learn how collaborations between academia and pharma are driving progress in diabetes care. In this episode, Dr. Melissa Thomas (Eli, Lilly & Company), Dr. Elizabeth Niemoller (Sanofi) and Prof. Dr. Michele Solimena (Helmholtz Zentrum München & Technical University of Dresden) join Vivienne Parry to unpack the power of partnerships.
The conversation covers:
The evolution of public-private collaborations in diabetes research
How projects like INNODIA and the Innovative Medicines Initiative (IMI) are accelerating translational breakthroughs
The growing importance of patient advocates in study design and advocacy
Why precompetitive science, shared data a...2025-06-0620 min
Diabetes Insights - Breakthroughs and InnovatorsProducing Beta Cells: Generation of Pancreatic islets from Stem Cells
Watch the full video on YouTube to join experts Prof. Raphael Scharfmann (INSERM, France) and Valeria Sordi (San Raffaele Diabetes Research Institute, Italy) as they explore the future of beta cell replacement therapies in diabetes.
They discuss the progress made in generating stem cell–derived beta cells, how insights from developmental biology have shaped clinical protocols, and the latest updates from ongoing clinical trials and translational research. They also examine the key challenges still facing the field, including immune rejection, long-term cell survival, and the complexities of scaling up production for widespread clinical use.
Learn mo...2025-05-3009 min
Diabetes Insights - Breakthroughs and InnovatorsAdvances in Diabetes Care: Technology in Hospitals, Pregnancy & Gestational Diabetes
Learn how diabetes technology is transforming inpatient and pregnancy care in the most recent episode of Diabetes Insights: Breakthroughs and Innovators podcast.
Today, Prof. Hood Thabit and Prof. Helen Murphy discuss how CGM and digital tools are changing clinical practice - from labour wards to emergency admissions - and the need for more integrated care systems, especially for gestational and type 2 diabetes.
Listen for insights on:
How CGM improves outcomes for pregnant women with type 1 diabetes
The challenges hospitals face managing diabetes without specialist staff
The importance of national policies and healthcare integration
Current...2025-05-2315 min
Diabetes Insights - Breakthroughs and InnovatorsThe Rise of GIP: From Biology to Medicine
Delve into the evolving story of GIP-based therapies and their role in type 2 diabetes care. In this episode, our expert guests explore how dual and triple agonists like tirzepatide are reshaping obesity and metabolic control, and why GIP is gaining renewed attention in diabetes pharmacology.
You can also explore each speakers' profiles as well as watch each speaker’s Lecturesession from the EASD Annual Meeting 2024 for deeper insights into incretin science, clinical outcomes, and next-generation therapies:
Prof. Michael Nauck's Profile and EASD 2024 Lecture
Dr. Alice Adriaenssens' Profile and EASD 2024 Lecture
2025-05-1613 min
Diabetes Insights - Breakthroughs and Innovators"Old and New" Islets for Type 1 Diabetes: From Transplant to Stem Cells
Watch the full video on YouTube to join experts Dr James Shaw (Newcastle University), Dr Timothy Kieffer (University of British Columbia & Fractal Health), and Dr Trevor Reichman (University of Toronto) for an in-depth conversation on the latest in cell therapies for type 1 diabetes as they explore how these therapies are transforming lives.
From the clinical use of islet transplants to scalable, gene-edited stem cells, this discussion explores how regenerative medicine is transforming care.
You can also watch each speaker’s lecture sessions from the EASD Annual Meeting 2024 for further insights into diabetes cell therapy, clinical outcomes, and fu...2025-05-0912 min
Diabetes Insights - Breakthroughs and InnovatorsFinding the Balance: Work-Life Balance in Research and AcademiaToday’s episode is special, as the topic was requested by members of the Early Career Academy. The spotlight is on work-life balance in academic medicine and research.
Dr Anna Krook from the Karolinska Institute in Sweden and Dr Benoit Gauthier from the Andalusian Molecular Biology and Regenerative Medicine Centre – CABIMER with the Ministry of Health of Andalusia in Spain, delve into the critical topic of work-life balance for everyone but specifically, early career academics.
Listen in as they discuss the unique challenges faced during this demanding period, including securing grants, managing teaching responsibilities, and navigating personal relationships. The conversation high...2025-05-0213 min
Diabetes Insights - Breakthroughs and InnovatorsEstablishing Diabetes Technology in a National Healthcare System: How the UK Revolutionised Diabetes Care
Watch the full video on YouTube to hear Professor Partha Kar’s insights into the UK’s trailblazing rollout of continuous glucose monitors (CGMs) and artificial pancreas technology for people with type 1 diabetes.
Discover how patient advocacy, data-led decision-making, and inclusive policymaking transformed diabetes care - and what other healthcare systems can learn from this example.
You can also watch Prof. Kar’s chaired sessions from previous EASD Annual Meetings for deeper insights into diabetes care innovation, patient-centred policy, and health equity.
Learn more about Professor Partha Kar and his groundbreaking work in diabet...2025-04-2510 min
Diabetes Insights - Breakthroughs and InnovatorsThe Future of Type 2 Diabetes - Where Are We Going?
Watch the full video on YouTube to explore the future of type 2 diabetes care through the lens of personalised medicine, precision diagnostics, and digital innovation. In this episode, our expert guests examine how sub-typing, AI-driven risk prediction, and early screening are changing the way we understand and manage type 2 diabetes.
You can also watch each speakers full lecture from the EASD Annual Meeting 2024 for deeper insights into diabetes phenotyping, clinical decision-making, and patient-centred care.
Learn more about our expert speakers and their pioneering research: Professor Emma Ahlqvist and her EASD 2024 lecture, and Professor Matthias Blüh...2025-04-1815 min
Diabetes Insights - Breakthroughs and InnovatorsWhen Sex is Ex - Sexual Problems in Diabetes
Watch the full video on YouTube to dive into the latest discussions on sexual health, intimacy, and the science behind human connection. This episode explores expert insights into the evolving landscape of sexual wellness, relationships, and medical advancements that shape our understanding of pleasure and health.
You can also watch the full session from the EASD Annual Meeting 2024 for more in-depth discussions on health, well-being, and medical research.
Learn more about our expert speakers and their groundbreaking work; Dr Aleksandra Uruska and Dr Marieke Dewitte. 2025-04-1110 min
EASL Video PodcastsEASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.
Learning objectives:
Understand the role of glucagon and glucagon-receptor in normal physiology and disease.
Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain insights into th...2025-04-041h 06
EASL PodcastsEASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.Learning objectives:Understand the role of glucagon and glucagon-receptor in normal physiology and disease.Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain in...2025-04-041h 06
Diabetes Insights - Breakthroughs and InnovatorsTargeting Obesity to Treat Heart Failure - With Preserved Ejection Fraction (HFpEF)
Watch the full video on YouTube to explore the latest insights into heart failure with preserved ejection fraction (HFpEF) and the impact of GLP-1 receptor agonists. Discover how weight loss and metabolic therapies could transform treatment for people with diabetes, obesity, and heart failure.
You can also watch the full session from the EASD Annual Meeting 2024 for more insights into cardiovascular health, diabetes management, and obesity care.
Delve deeper into the professional portrait of our speakers; Melanie Davies, Mark Petrie and Mikhail Kosiborod2025-04-0409 min
Diabetes Insights - Breakthroughs and InnovatorsAvoiding Complications at Onset - The Future of Type 1 Diabetes Screening and CareIn this episode of Diabetes Insights, we explore the power of screening in type 1 diabetes and the potential for early intervention. Host Vivienne Parry speaks with EASD President, Prof. Chantal Mathieu and Prof. Annette Ziegler about groundbreaking research into detecting type 1 diabetes in its earliest stages.
With new disease-modifying therapies on the horizon, early screening is no longer just about preventing complications at diagnosis but it could delay the onset of diabetes and open doors to future treatments.
We discuss how registries, European-wide collaboration, and real-world screening initiatives are shaping the future of early detection, patient monitoring, and clinical trials.
...2025-03-2812 min
Diabetes Insights - Breakthroughs and InnovatorsShaping Policy for Better Diabetes Care - European Diabetes Forum (EUDF)
Watch the full video on YouTube to explore the latest insights into diabetes policy and advocacy. Learn how the European Diabetes Forum (EUDF) is driving unified action to improve diabetes care across Europe.
Discover why early intervention is a financial investment, how obesity and diabetes policies are evolving, and what the new European Parliament means for healthcare priorities.
For additional insights, watch the full session on the EASD Media Centre and delve deeper into the professional portrait of our speaker, Bart Torbeyns.2025-03-2108 min
Diabetes Insights - Breakthroughs and InnovatorsSaving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW Trial
The FLOW study continues to deliver groundbreaking insights into the benefits of GLP-1 receptor agonists for chronic kidney disease (CKD) in people with type 2 diabetes. In this episode, experts discuss the latest findings, revealing a 24% reduction in kidney disease progression, 18% reduction in major adverse cardiovascular events (MACE), and 20% reduction in total mortality - proving that this treatment saves hearts, kidneys, and lives.
Watch the full video on YouTube to learn how GLP-1 receptor agonists provide metabolic, cardiovascular, and renal benefits across different CKD stages, why early intervention is key, and how new research is uncovering the mechanisms...2025-03-1417 min
Diabetes Insights - Breakthroughs and InnovatorsCan We Screen for Type 2 Diabetes using Voice?
Watch the full video on YouTube to explore the latest insights on AI-driven voice analysis for type 2 diabetes screening. Learn how subtle vocal changes, undetectable to the human ear, could provide a new tool for early diabetes detection.
Discover how AI and deep learning are advancing diabetes research and what this means for future screening methods by watching the full session from the EASD 2024 Annual Meeting for more insights or exploring more about our speaker, Dr. Fagherazzi (Luxembourg Institute of Health).2025-03-0707 min
Diabetes Insights - Breakthroughs and InnovatorsExercise is Medicine - Physical Activity and Insulin Action in Diabetes
Watch the full video on YouTube to explore Prof. Juleen Zierath’s groundbreaking research on exercise metabolism, and diabetes.
Learn more about how physical activity improves insulin sensitivity, the role of circadian rhythms in glucose metabolism, and how personalized exercise interventions could transform diabetes care.
You can also explore more about our speaker, Professor Juleen Zierath (Karolinska Institute, Sweden), and her award-winning research from the EASD Annual Meeting 2024 for deeper insights into the future of metabolic health and diabetes treatment.2025-02-2810 min
Diabetes Insights - Breakthroughs and InnovatorsIslet Networks Regulating Insulin Secretion - A Debate
Watch the full video on YouTube to explore the latest insights on islet biology and its impact on diabetes research. Learn more about the role of alpha and delta cells in glucose regulation and how targeting islet networks could shape future diabetes therapies. You can also explore more about our speakers: Mark Huising (University of California, Davis) and Guy Rutter (University of Montreal) from the EASD Annual Meeting 2024 for more insights and the latest research and developments in diabetes care.2025-02-2109 min
Diabetes Insights - Breakthroughs and InnovatorsDiabetologia Journal in Review - Innovations, AI and the Future of Diabetes ResearchIn this episode, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, joins us to discuss the journals accomplishments over the past year and its vision for the future of diabetes research. From embracing AI in research processes to addressing global health disparities, Prof. Mulder highlights how Diabetologia remains at the forefront of the field.
He also shares his excitement about advancements in stem-cell and beta-cell research, the potential of precision medicine, and the role of incretin-based therapies, Prof. Mulder previews Diabetologia's special symposium on technology in diabetes care, co-created with patients, and explores how collaborative efforts are driving innovation in treatment and...2025-02-1409 min
Diabetes Insights - Breakthroughs and InnovatorsTalking Guidelines - New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver DiseasesIn this episode, Prof. Frank Tacke (Charité – Universitätsmedizin Berlin), Prof. Michael Roden (University of Düsseldorf), and Prof. Hannele Yki-Järvinen (University of Helsinki) discuss the groundbreaking new guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD).
The episode explores the shift from the term "NASH" to MASLD, addressing the rationale behind this change and its implications for reducing stigma and improving diagnosis. The experts delve into innovative diagnostic tools, such as FIB-4 and transient elastography, and the evolving role of GLP-1 receptor agonists and emerging liver-specific therapies.
Join us to learn how multidisciplinary collaboration between hepatologists, diabetologists, and obesity specia...2025-02-0717 min
Diabetes Insights - Breakthroughs and InnovatorsPutting Diabetes on the Agenda - How to Get Policymakers on BoardIn this episode, we explore the vital role of National and European diabetes forums, respectively, in shaping policies and improving care for people living with diabetes. Featuring Bogdan Timor (Romanian Diabetes Forum) and Frank Nobels (Belgian Diabetes Forum), the discussion highlights how collaborative efforts, and shared strategies can drive early detection, prevention, and better management of diabetes across Europe. From Romania's groundbreaking diabetes prevention law to Belgium's integrated care and data projects, this episode showcases the power of collective advocacy in transforming diabetes care.2025-01-3110 min
Diabetes Insights - Breakthroughs and InnovatorsHelp! I Need Somebody - Complex Diabetes Cases in the Emergency RoomIn this episode, Aoife Egan and Daniel Morganstein discuss the complexities of managing glycaemic emergencies in special patient populations. From diabetic ketoacidosis (DKA) during pregnancy to hypoglycaemic crises triggered by cancer treatments, they explore the importance of multidisciplinary collaboration, education, and awareness in delivering timely and effective care.2025-01-2410 min
Within Range: Demystifying Diabetes TechWithin Range: Demystifying Diabetes Tech Interview with Prof. Jean-Pierre RivelineOmnipod® 5 provides impressive quality of life improvements for people living with diabetes (PWD)Recorded at the 60th Annual EASD Scientific Meeting in Madrid, Spain, our host, Cindy Pickering, brings you a conversation with Professor Jean-Pierre Riveline. Prof. Riveline is a senior practitioner in diabetology-endocrinology at Lariboisière hospital as well as a Professor in endocrinology, and the Leader of the Centre Universitaire du Diabète et de ses Complications (CUDC), Lariboisière Hospital in Paris, France. Together Cindy and Prof. Riveline discuss revolutionary AID technology and the impressive impact that Omnipod 5 is making on both gly...2025-01-2020 min
Diabetes Insights - Breakthroughs and InnovatorsOnce Weekly Insulins - A Paradigm Change for Basal Insulin ReplacementQWINT: A Paradigm Shift in Insulin Therapy
In this episode, Harpreet Bajaj, Carol Wysham, and Richard Bergenstal explore the revolutionary QWINT program, a once-weekly insulin therapy currently in development. With a unique mechanism of action resulting in a 17-day half-life, QWINT has the potential to transform diabetes care by reducing the treatment burden for patients and caregivers alike.
The discussion covers key findings from the program’s trials, including strong patient preference despite challenges in type 1 diabetes management, and highlights the benefits for older patients and those requiring assistance with daily activities. Join us to learn how QWINT is poised to...2025-01-1711 min
Diabetes Insights - Breakthroughs and InnovatorsThe Future of Type 1 Diabetes - Will We See Prevention or Cure?In this first episode of the year, our very own president Prof. Chantal Mathieu and other leading experts explore the future of type 1 diabetes. Join Vivienne Parry as she sits down with renowned experts - EASD President Prof. Chantal Mathieu, Dr. Peter Rossing, and Dr. Rory McCrimmon - to discuss the future of type 1 diabetes.
From global screening initiatives to cutting-edge research on islet transplantation and organ protection, this conversation highlights how far we've come - and the exciting journey ahead!
Tune in for insights from experts dedicated to improving lives through groundbreaking research and solutions.2025-01-1018 min
Diabetes Insights - Breakthroughs and InnovatorsIdentifying the Genetic Causes of Neonatal DiabetesIn this episode, Dr Elisa De Franco, recipient of the 2024 EASD Minkowski Award, takes us on a journey through her groundbreaking research into neonatal diabetes. Dr De Franco’s work has revolutionised the understanding and treatment of this rare form of diabetes, diagnosed in babies under six months old. From identifying 10 - 15 genetic mutations linked to neonatal diabetes to shedding light on beta cell biology, Elisa’s discoveries are transforming lives and advancing diabetes research.
Join us to explore the global impact of Exeter's diagnostic service, the role of next-generation sequencing in genetic research, and how rare genetic mutations provide vita...2024-12-2009 min
Diabetes Insights - Breakthroughs and InnovatorsMetabolic Mastermind - Adipose Tissue's Role in Energy and Glucose ControlAdipose tissue isn't just "fat" - it's a remarkable endocrine organ with transformative impacts on health and diabetes. In this episode, discover groundbreaking insights from Dr Alice Williamson of Queen Mary University, London, and Dr Lori Goodyear of Harvard Medical School.
Learn about the genetic factors behind insulin resistance and the revolutionary role of exercise in remodelling adipose tissue. From genetic breakthroughs to potential therapies, this discussion unpacks the future of diabetes care. Find out why fat is more than just a roll around your middle - it’s a key player in metabolic health!2024-12-1309 min
Diabetes Insights - Breakthroughs and InnovatorsThe Forgotten Few or Many? Diabetes Care for People at Margins of SocietyIn this episode, Alice Rickford and Andrzej Kokoszka discuss the complex challenges of managing diabetes in disadvantaged communities and among individuals with mental health conditions. Alice Rickford, a healthcare professional from London, highlights barriers like homelessness, access to care, and the stigma faced by people living with diabetes in vulnerable situations. Andrzej Kokoszka, from Poland, sheds light on the relationship between mental health and diabetes, focusing on depression, body image issues, and the role of self-management. The conversation offers practical advice for clinicians, emphasizing the need for a holistic, patient-centred approach to care, and how building trust and providing emotional...2024-12-0614 min
Diabetes Insights - Breakthroughs and InnovatorsGlobal Perspectives on DiabetesIn Episode 3 of our podcast, experts from Argentina, Mexico, Pakistan, and Sri Lanka share a comprehensive view of the diabetes epidemic in their countries. The conversation highlights the alarming rise in diabetes and pre-diabetes cases, touching on the challenges faced by their healthcare systems and the urgent need for government intervention. Dr. Prasad Katulanda (Sri Lanka) discusses the exponential growth in diabetes rates, while Dr. Abdul Basit (Pakistan) talks about the push for government action and better healthcare funding. Dr. Javier Farias (Argentina) and Dr. Leonardo Mancillas (Mexico) also share the growing concern over obesity and the steps their countries...2024-11-2922 minWithin Range: Demystifying Diabetes TechThe Simplicity of Omnipod® 5 allows a wider range of people with diabetes to try Automated Insulin Delivery (AID)Recorded at the 60th Annual EASD Scientific Meeting in Madrid, Spain, our host, Cindy Pickering, brings you a conversation with Dr. Jackie Elliott. Dr. Elliott is the clinical lead for diabetes at Sheffield Teaching Hospitals in the United Kingdom. Together Cindy and Dr. Elliott discuss revolutionary AID technology and how the simplicity of Omnipod 5 is changing clinical practice. Dr. Elliott describes some impactful case examples of how Omnipod 5 has improved outcomes for not only the person living with diabetes but has also given freedom back to the whole family. Some references to the Insulet Sponsored Symposium at EASD are made...2024-11-2739 min
Diabetes Insights - Breakthroughs and InnovatorsWhat the Future Will Bring - Diabetes Care in 2030Episode 2 features Matthias Blüher and Anette Ziegler, two leading experts in diabetes research, as they share their insights into the future of diabetes care by 2030. The conversation explores innovative developments in the prevention and treatment of both Type 1 and Type 2 diabetes, with a focus on early diagnosis, immune interventions, and the potential of incretin-based therapies. Dr. Blüher discusses the exciting possibilities of personalised medicine and new pharmacotherapies, while Dr. Ziegler emphasizes the importance of primary prevention and the latest research into viral triggers. This episode delves into the evolving landscape of diabetes care and the potential to revolutionise tr...2024-11-2213 min
Diabetes Insights - Breakthroughs and InnovatorsDiabetes Remission - is Type 2 Diabetes Reversible?Our first episode features Dr. Roy Taylor, a leading diabetes researcher and recipient of the prestigious EASD Claude Bernard Prize, discussing groundbreaking insights into type 2 diabetes remission. He shares his journey in proving that type 2 diabetes can, in many cases, be reversed through targeted weight loss to reduce fat in the liver and pancreas. Dr. Taylor recounts the challenges he faced in gaining acceptance for his theories and highlights the role of media and patient stories in spreading awareness. His approach has influenced a shift in treatment options, including the development of a national programme in the NHS for diabetes...2024-11-1512 min
Horse Chats0978: Lee Davis - Horsemanship and Equine Assisted Skills Development - EASD - with Lee DavisHorsemanship and Equine Assisted Skills Development - EASD - with Lee Davis Contact Details for this Episode are available on www.HorseChats.com/LeeDavis Music - BenSound.com Interviewed by Glenys Cox2024-11-0223 min![Expose MASH [Formerly NASH]](https://image.simplecastcdn.com/images/bc2d8a5e-50fa-4e66-967c-16915bf87f1d/e1161233-4089-43d8-91c6-1fae6c77b5ed/3000x3000/mash-podcast-series-coverart.jpg?aid=rss_feed)
Expose MASH [Formerly NASH]A Practical Translation Guide: Turning MASH Guidelines Into PracticeOn this episode, join experts Mazen Noureddin, MD, MHS (Transplant Hepatologist and Professor of Medicine at Houston Methodist Hospital), Rita Basu, MD (Endocrinologist and Endowed Professor of Diabetes Scienceat University of Alabama at Birmingham) and Mary Rinella, MD (Transplant Hepatologist and Professor of Medicine at The University of Chicago Medicine), as they explore the most recent MASH guidelines. The experts discuss the different guidelines available, examining their common features and subtle differences for patient screening and the management of MASLD and MASH. They then look to the future, highlighting the emerging data that may influence the next iterations of th...2024-10-1720 min
Conversaciones en DiabetesNovedades del Congreso Europeo de Diabetes - EASD 2024. Dr Alejandro DainBienvenidos a un nuevo episodio de la 5ta temporada de Conversaciones en Diabetes. Hoy vamos a tener un formato bien dinámico, para poder ponernos al día con las novedades del Congreso Europeo de Diabetes, que se llevó a cabo en Madrid, del 9 al 13 de septiembre.
Este año fue muy especial para la EASD (European Association for the Study of Diabetes), ya que se cumplieron 60 años desde su creación. Su presidente, la Dra Chantal Mathieu, dió un discurso de apertura super motivador, poniendo el foco en los grandes avances en el tratamiento de la diabe...2024-10-1050 min
Springer Health+ IME: Podcast to PracticeKey CGM Updates and Highlights from the EASD 2024 Conference | S3E3Techniques for implementing CGM in primary care
In this episode, Dr. Jennifer Green dives into several sessions from the EASD 2024 meeting held in Madrid, Spain (September 9-13, 2024), covering topics on the impact of CGM use in T2D on hemoglobin A1C in patients using insulin and non-insulin therapies; hospitalization and ER rates; in non-ICU hospitalized patients; in hospitalized sub-populations of patients who had undergone cardiac surgery, and in sub-populations who had diabetic ketoacidosis. In addition, Dr. Green also covered the impact of hyperglycemia on one-year mortality in older patients using insulin, as well as a new glucose monitoring...2024-10-0325 min
Studio Langerhans#19 SPECIAL het laatste nieuws: EASD 2024Deze speciale podcast van studio Langerhans is live vanaf het grootste diabetescongres ter wereld, de EASD, in Madrid. Vier dagen lang presenteren wetenschappers uit de hele wereld hier hun recente onderzoek over diabetes en alles wat daarmee samenhangt. In deze aflevering bespreken we met professor Daniel van Raalte, internist en Bertien Hart, kaderhuisarts enkele interessante hoogtepunten voor de eerste lijn. Aan bod komen o.a. de uitkomsten van een groot onderzoek naar de beschermende werking van GLP1- ra op de nieren, het beste voedingspatroon bij een vervette lever en de rol van metformine bij pre-diabetes.
2024-09-2538 min
Surfing the MASH TsunamiS5 - E22.4 - Healthy Livers, Healthy Lives: The Role Of The Updated EASL MASLD Guidelines And Big DataHealthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and consider the role of Big Data in early MASLD screening. Roger asks Jeff whether he considers the updated MASLD CPG a step forward. Jeff praises the guidelines as "amazing" and suggests that one reason is that EASD and EASO are partners in drafting and promoting them.Roger's next question to Jeff addresses the idea that Big Data can provide a set of common variables th...2024-07-0710 minSurfing the MASH TsunamiS5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines00:00:00 - Surf's Up: Season 5 Episode 21 One important session at the EASL Congress 2024 involved the presentation of the new MASLD Clinical Practice Guidelines. CPG co-authors Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to share their perspectives on the guidelines' development some key recommendations. 00:09:36 - Revising the guidelines Roger asks the co-authors to describe the process that led to the 2021 decision to revise the guidelines. EASL was the initial driver; EASD and EASO joined the process. They formed a committee of 15 leaders and assembled a Delphi panel of 46 individuals from different stakeholder communities. ...2024-06-2752 min
Radio LinguasObserva_Acción Acollida da ESADg e EASD Ramón Falcón de Lugo na EOI de VigoA EOI de Vigo participa no programa de innovación chamado Observa_Acción que consiste en observación interescolar e intraescolar. Na Etapa Acolle, estamos "emparellados" con dous centros de réxime especial, a ESADg e a EASD Ramón Falcón. Na sesión de acollida de profesorado das escolas de ensinanzas de réxime especial, compañeiros dos tres centros involucrados comparten perspectivas sobre o trato de erro e a experiencia de observar aulas en outro centro de ensino.
María e Noelia da Escola de Arte e Superior de Deseño Ramón Falcón, Lugo
Vanesa...2024-05-1626 min
Radio Linguas (Radio Linguas)Observa_Acción Acollida da ESADg e EASD Ramón Falcón de Lugo na EOI de Vigo
A EOI de Vigo participa no programa de innovación chamado Observa_Acción que consiste en observación interescolar e intraescolar. Na Etapa Acolle, estamos “emparellados” con dous centros de réxime especial, a ESADg e a EASD Ramón Falcón. Na sesión de acollida de profesorado das escolas de ensinanzas de réxime especial, compañeiros dos tres centros involucrados comparten perspectivas sobre o trato de erro e a experiencia de observar aulas en outro centro de ensino.
María e Noelia da Escola de Arte e Superior de Deseño Ramón Falcón, Lugo
Vanesa da...2024-05-1526 minRadio Linguas (Radio Linguas)Observa_Acción Acollida da ESADg e EASD Ramón Falcón de Lugo na EOI de Vigo
A EOI de Vigo participa no programa de innovación chamado Observa_Acción que consiste en observación interescolar e intraescolar. Na Etapa Acolle, estamos “emparellados” con dous centros de réxime especial, a ESADg e a EASD Ramón Falcón. Na sesión de acollida de profesorado das escolas de ensinanzas de réxime especial, compañeiros dos tres centros involucrados comparten perspectivas sobre o trato de erro e a experiencia de observar aulas en outro centro de ensino.
María e Noelia da Escola de Arte e Superior de Deseño Ramón Falcón, Lugo
Vanesa da...2024-05-1526 min
SBDN253 - Refletindo sobre GLP-1/GIP/SGLT2 - cobertura EASDN253 - Refletindo sobre GLP-1/GIP/SGLT2 - cobertura EASD by SBD2024-02-0827 min
Diabetes a DebateNovedades congreso EASD 2023Diabetes a Debate es el podcast del grupo de diabetes de la Sociedad Española de Endocrinología y Nutrición. En este capítulos planteamos una revisión completa sobre los avances más significativos de la última edición del congreso de la EASD en el año 2023. Un formato destinado a profesionales sanitarios que cuenta con el patrocino de SANOFI.2023-12-2719 min
Diabetes Knowledge into Practice PodcastCongress special: Highlights from EASD 2023Join Prof. Francesco Giorgino and Dr. Erika Bezerra Parente as they identify some takeaways from EASD 2023, including data and discussions on treatment non-adherence, SGLT2 inhibitors, and stigma
For more free education, go to diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.
Faculty disclosures
Prof. Francesco Giorgino
Grants or contracts: Eli Lilly, Roche Diabetes Care
Consulting: Eli Lilly, Novo Nordisk
Honoraria for lectures, presentations and education even...2023-12-1114 min
O-Ton DiabetologieEine Reise durch die Geschichte der Diabetesforschung mit Dr. Viktor JörgensWer hat denn nun wirklich das Insulin entdeckt und damit die Insulin-Behandlung möglich gemacht? Und hätte Insulin schon viel früher entdeckt werden können? Das wollen wir heute von Dr. Viktor Jörgens erfahren. Er ist Arzt und war von 1988 bis 2015 Direktor der Europäischen Diabetes Gesellschaft (EASD). Darüber hinaus ist er ein großer Kenner der Diabetesforschung und weiß Geschichten zu erzählen, von Forscherinnen und Forschern, die für entscheidende Fortschritte in der Diabetologie gesorgt haben. Vieles davon steht in seinem Buch „Die Geschichte der Diabetesforschung – vom Opium zum Insulin“. Mit Dr. Jörgens begeben wir uns in...2023-11-0847 min
Podcastul Raportuldegardă.roMedicina de Precizie în Managementul Diabetului Zaharat | Dr. Marius Geantă | #știința360În cadrul ediției de pe 17 octombrie 2023 a emisiunii #știința360 de pe Radio România Cultural, Dr. Marius Geantă, Președintele Centrului pentru Inovație în Medicină, a comentat cele mai recente noutăți din domeniul medical publicate pe Raportuldegardă.ro. Puteți asculta emisiunea live, în fiecare marți, ora 14:00.
Asociația Americană pentru Diabet (ADA), Asociația Europeană pentru Studiul Diabetului (EASD) și Fundația Novo Nordisk au publicat în Nature un document de consens privind oportunitățile pentru implementarea medicinei de precizie în managementul diabetului zaharat.
Documentul a fost realizat de 200 de experți din 28 de țări...2023-10-1929 min
Docs Who LiftTirzepatide updates from EASDDrs. Karl and Spencer chat about some of the new tirzepatide studies including SURMOUNT-4 from the EASD
2023-10-1737 min
Diabetes Connections | Type 1 DiabetesIn the News... EASD updates from Dexcom, Vertex, antivirals for #T1D, new guidelines for CGM at school and moreIt’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: lots of news from the EASD conference, including info from Dexcom, Vertex, and more, the ADA issues new guidelines for CGM use at school around caregivers' ability to follow, a new study says women should be screened at a younger age for type 2 diabetes, and congrats to Lauren Dahlin, who lives with type 1, for qualifying for the Ironman race in Hawaii. Find out more about Moms' Night Out Please visit our Sponsors & Par...2023-10-0608 min
Embracing Diabetes, compassion, community and creativity"Listening Makes us Better Doctors." Great advice from a doctor on the front lines of diabetes careSend us a textOn this episode of Embracing Diabetes, we had the pleasure of talking to Dr. Ann Peters. Anne is one of the world's leading diabetes clinicians and clinical researchers, and an influential advocate and policy advisor for new diabetes treatment guidelines and increased access to care. Dr. Peters is dedicated to bringing cutting edge diabetes care to all walks of life, including an underserved lower literacy population. We have a wonderful conversation where we talked about her own personal journey with diabetes, her diverse clinical work in Los Angeles, and her perspective on what w...2023-04-1436 min
Embracing Diabetes, compassion, community and creativity"Listening Makes us Better Doctors" Great advice from a dr. on the front lines of diabetes careFeatured on this Episode:Anne L. Peters, MD, is one of the world’s leading diabetes clinicians and clinical researchers and an influential advocate and policy advisor for new diabetes treatment guidelines and increased access to care. Dr. Peters is dedicated to bringing cutting-edge diabetes care to all walks of life, including an underserved lower-literacy population.She works with the L.A. County Department of Health Services on a county-wide diabetes program, and she established the Community Diabetes Initiatives Research Center (CDI) with Children’s Hospital Los Angeles (CHLA). Dr...2023-04-1439 min
The Huddle: Conversations with the Diabetes Care TeamHelping Clients/Patients Meet Targets with GLP-1 and GIP/GLP-1 Receptor Agonists with Christie SchumacherChristie Schumacher PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, joins The Huddle to talk through the use of GLP-1 and GIP/GLP-1 receptor agonists for your people with type 2 diabetes. You’ll learn what medications fall into the class of GLP-1 and GIP/GLP-1 receptor agonists, how they work and the benefits they can offer people with type 2 diabetes. These medications can be a useful tool in the therapeutic toolkit as highlighted in the recently updated ADA/EASD consensus statement, so this episode will offer practical considerations when initiating GLP-1 and GIP/GLP-1 receptor agonists in patients and managing pos...2022-11-1619 minDiabetes Knowledge into Practice PodcastConference special: EASD 2022 Highlights | With Prof. Apostolos TsapasThis year’s EASD was a hybrid event, with delegates able to join either in person in Stockholm, or online via the virtual platform. As usual, the congress featured a huge number of presented abstracts, symposia and other sessions. This year also saw the publication of the updated ADA-EASD consensus report on the management of hyperglycaemia in type 2 diabetes.
Join us as we speak to Professor Apostolos Tsapas about his conference highlights, including:
- 2022 ADA-EASD consensus report on the management of hyperglycaemia in type 2 diabetes
- 44-year follow-up results from the UKPDS trial...2022-11-1418 min
Primary Care GuidelinesCardiovascular health and diabetesMy name is Fernando Florido and I am a GP in the United Kingdom. In this podcast I I give my summary of the online course by the EASD learning website “Cardiovascular health and diabetes”.This podcast will be saved on a website.There is also a YouTube video on this subject and other NICE guidance. You can access the channel here:https://www.youtube.com/channel/UClrwFDI15W5uH3uRGuzoovw The online course can be found on the EASD learning website:https://easd-elearning.org/courses/cardiovascular-health-and-diabetes/ I...2022-10-3020 min
Diabetes in Primary CareCardiovascular health and diabetesMy name is Fernando Florido and I am a GP in the United Kingdom. In this podcast I I give my summary of the online course by the EASD learning website “Cardiovascular health and diabetes”.This podcast will be saved on a website. There is also a YouTube video on this subject and other NICE guidance. You can access the channel here:https://www.youtube.com/channel/UClrwFDI15W5uH3uRGuzoovw The online course can be found on the EASD learning website:https://easd-elearning.org/courses/cardiovascular-health-and-diabetes/ In...2022-10-3020 min
Diabetes a DebateNovedades en DM1 en el congreso de la EASD 2022Las doctoras Ana Chico y Beatriz Lardiés conversan sobre las novedades presentadas en el último congreso de la EASD 2022 celebrado en Estocolmo. Dm1 al día es un podcast del grupo de diabetes de la SEEN con el patrocinio de SANOFI.2022-10-2512 min
Ett samtal om diabetesRapport från EASDI vårt tolfte avsnitt gästas vi av Sheyda Sofizadeh, om årets EASD kongress. Sheyda är Distriktssköterska och Specialistsjuksköterska i diabetesvård samt föreläsare. Sheyda arbetar på Närhälsan Dalabergs vårdcentral i Uddevalla. Avsnittet är ca 17 minuter långt. Vid synpunkter, förslag på samtalsämnen eller frågor kan ni skriva till oss på ett samtalomdiabetes@sanofi.com MAT-SE-2200768 2022-10-1916 min
Afya Endocrinopapers#216-Podcast Endocrinopapers - Novo guideline de diabetes ADA/EASDPodcast Endocrinopapers - Novo guideline de diabetes ADA/EASD2022-10-0428 min
Diabetes Connections | Type 1 Diabetes"What We Wish You Knew - and Why" - A patient-centered panel from #EASDMany of you tuned in virtually to EASD or maybe you were lucky enough to travel there! There was one talk at the European Association for the Study of Diabetes that really got my attention: the #dedoc° symposia “What we wish you knew — and why” which featured advocates speaking on topics that are relevant to people living with diabetes. The topic for this one is: Novel forms of online peer support developed during COVID; how did communities around the world stay connected? #dedoc° was founded in 2012 by Bastian Hauck, who created the Twitter hashtag #dedoc to host weekly T...2022-10-0444 min
Diabetes Core UpdateSpecial Edition: ADA-EASD Hyperglycemia Management 2022In this special podcast we will be focusing on the Consensus Report: Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). This report was simultaneously published in Diabetologia and Diabetes Care. The report is available at: https://diabetesjournals.org/care/article/doi/10.2337/dci22-0034/147671/Management-of-Hyperglycemia-in-Type-2-Diabetes . Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Van...2022-09-3025 min
De Diabetes Podcast#59 De EASD in Stockholm. Nothing about us without us.Van 19 - 23 september vond de EASD (The European Association for the Study of Diabetes) plaats in Stockholm. Op uitnodiging van Medtronic en Dedoc mocht ik hier vijf dagen lang bij aanwezig zijn. Hoe dat was, welke nieuwe ontwikkelingen ik heb gezien en gehoord en hoe zo'n wetenschappelijke sessies eruit zien, je hoort het allemaal in deze podcast!
Disclosure: Medtronic en Dedoc hebben mijn vlucht, verblijf en toegang tot de EASD betaald. Ik krijg niet betaald voor het maken van verdere content rondom dit congres. Alle ervaringen die ik deel zijn op persoonlijke titel, omdat ik het belangrijk...2022-09-2334 min
Diabetes in Primary CareEASD ADA consensus guidelines on type 2 diabetesEpisode: EASD ADA consensus guidelines on the overall approach in glucose lowering medication in type 2 diabetes This podcast is intended for healthcare professionals. My name is Fernando Florido and I am a GP in the United Kingdom. In this episode I go through the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) consensus guidelines on the overall approach in glucose lowering medication in type 2 diabetes. I will firstly give you a list of the changes to the previous consensus recommendations followed by a description of the consensus recommendations flowchart o...2022-09-1018 min
Primary Care GuidelinesEASD ADA consensus guidelines on type 2 diabetesEpisode: EASD ADA consensus guidelines on the overall approach in glucose lowering medication in type 2 diabetes This podcast is intended for healthcare professionals. My name is Fernando Florido and I am a GP in the United Kingdom. In this episode I go through the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) consensus guidelines on the overall approach in glucose lowering medication in type 2 diabetes. I will firstly give you a list of the changes to the previous consensus recommendations followed by a description of the consensus recommendations flowchart o...2022-09-1018 min
Der Zuckerdetektiv | Der Diabetes-PodcastIntervallfasten: Wie sinnvoll ist das zum Abnehmen?Ein Überblick zur Abnehmmethode bei Diabetes Typ 2
5:2, 1:1,18:6 - hinter diesen Abkürzungen verbergen sich verschiedene Arten des Intervallfastens. Also eine Abnehmmethode, die dabei helfen kann, Gewicht zu verlieren und dabei einfach umzusetzen ist. Gerade bei Typ-2-Diabetes ist das oft Teil der Therapie. Wie die Methode funktioniert und ob das bei Diabetes sinnvoll sein kann, findet Host Sabine Pusch in dieser Folge heraus. Außerdem hat sie ein paar Tipps, damit es mit dem Fasten klappt.
Alle 14 Tage am Freitag erscheint eine neue Folge. Habt Ihr Fragen, Anregungen oder Kritik? Dann schreibt uns gerne an redaktion@gesundheit-hoeren.de2022-08-0533 min
Diabetes Knowledge into Practice PodcastConference special: ADA 2022 | With Prof. Jennifer GreenThe ADA 2022 was full of interesting symposia, updates on ongoing clinical trials, and a draft of an updated ADA-EASD consensus report. This year’s conference also put particular emphasis on weight management in the setting of type 2 diabetes as well as its associated cardiovascular and kidney comorbidities.
Join us as we speak to Professor Jennifer Green about her conference highlights, including:
- Draft ADA-EASD Consensus Report
- Results from the SURMOUNT-1 clinical trial of tirzepatide in people with obesity
- Further data for dual and triple incretin agonists and their potential fu...2022-06-1717 minDiabetes Knowledge into Practice PodcastNASH: Advances in non-invasive screening | With Dr Kenneth CusiThis is a special episode brought to you in association with Hepatology Knowledge into Practice.
NASH occurs in around 20% of individuals with NAFLD, and puts patients at high risk of poor outcomes including cardiovascular events and hepatocellular carcinoma. With people with type 2 diabetes and obesity at significantly increased risk for developing NAFLD, how can we identify those with NASH?
In this podcast episode, we are joined by Dr Kenneth Cusi to discuss how patients can be risk stratified using non-invasive biomarkers and imaging techniques.
By completing this activity you can qualify for 0.25 CME...2022-05-1614 min
Podcast zu Diabetes Knowledge in PracticeEASD 2021 | Mit Prof. Stephen BainDiese Woche haben wir weitere Kongress-Highlights von der Jahrestagung 2021 der European Association for the Study of Diabetes (EASD), die vom 28. September bis 1. Oktober online stattfand. Hören Sie sich den Kommentar von Prof. Steve Bain zu den Highlights an:- Ergebnisse der TriMaster-Studie- Kardiovaskuläre Ereignisse unter Semaglutid mit und ohne Metformin (Post-hoc-Analyse von SUSTAIN 6 und PIONEER 6)- Weitere Ergebnisse aus dem SURPASS-Programm- Intraorganischer Fettgehalt während der durch Gewichtsabnahme induzierten Remission von Typ-2-Diabetes bei Menschen mit normalem oder erhöhtem BMI (Daten aus ReTUNE und DiRECT)Fü...2022-03-2516 minEtt samtal om diabetesEASD 2021Välkommen till vårt allra första avsnitt där vi bjudit in Björn Eliasson, professor och överläkare vid diabetescentrum på Sahlgrenska universitetssjukhuset i Göteborg, för att samtala runt årets EASD, vilka var höjdpunkterna, vad saknades och hur kommer framtidens kongresser se ut.Vid synpunkter, förslag på samtalsämnen eller frågor kan ni skriva till oss på ettsamtalomdiabetes@sanofi.com MAT-SE-2101003 v.1.0 okt 20212021-10-1213 min
法米賣藥仔EP16【米編講 糖2】法米醫藥─數位控糖&胰島素「監控?」ft.小鍾醫師在國家機器功力越來越強大之下
今天再次邀請到小鍾醫師
與我們分享最近很夯的「數位控糖」—連血糖都監控啦!
延伸閱讀：
醫材：https://www.biospace.com/article/releases/biocorp-and-sanofi-announce-a-partnership-to-fit-solostar-insulin-pens-with-mallya-technology-worldwide/
EASD最新發表：https://www.easd.org/virtualmeeting/home.html#!contentsessions/34132021-02-0713 min
Podcast zu Diabetes Knowledge in PracticeKommende und in Entwicklung befindliche Therapeutika für Typ-2-DiabetesDa auf den letzten Kongressen neue Daten und Entwicklungen vorgestellt wurden, erschien es uns gut, über Therapeutika in der Entwicklung und ihre vermutliche Rolle im Management von Typ-2-Diabetes zu berichten. In dieser Folge geht es um das einmal wöchentlich einzunehmende Basalinsulin Ikodec, den GLIP-1/GIP-Agonisten Tirzepatid und den neuartigen oralen Blutzuckersenker Imeglimin.Diese Woche ist unser Gast Dr. Athena Philis-Tsimikas, Corporate Vice President des Scripps Whittier Diabetes Institute von Scripps Health und Director of Community Engagement am Scripps Research Translational Institute in San Diego, Kalifornien.Verweise:- Bajaj H, et al. Eff...2021-01-0415 min
Ernesto CastroLa idea filosófica del diseño | Diálogos 2020Conferencia impartida por Ernesto Castro en la EASD (Escuela de Arte y Superior de Diseño) de Valencia, en el marco del congreso Diálogos 2020. Fecha de grabación: miércoles, 29/01/2020, entre las 12:30 y las 14:00 de mediodía. Gracias a los estudiantes de la EASD por la asistencia a la conferencia y el montaje posterior de este vídeo.
Web de la EASD: http://www.easdvalencia.com/
Publicación original del vídeo: http://www.easdvalencia.com/cat2020-11-061h 31
DM1 Al díaCongreso de la EASD 2020 resumenLas doctoras Noemí González y Sharona Azriel hacen un repaso pormenorizado del último congreso de la EASD 2020 en el podcast DM1 al día, de la Sociedad Española de Endocrinología y Nutrición, patrocinado por Sanofi.2020-10-1314 min
Medicine Matters diabetesEASD 2020: Highlights from the Editorial Board (with Sanjay Kalra, John Wilding and Lori Berard)Sanjay Kalra, John Wilding and Lori Berard from the Medicine Matters diabetes Editorial Board reflect on their research highlights from this year’s virtual 56th EASD Annual Meeting. Find more on Medicine Matters diabetes2020-10-0739 minMedicine Matters diabetesWhy psychosocial care matters: The psychological impact of hypoglycemia (with Christel Hendrieckx)In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. In this episode, Dr Christel Hendrieckx, from the Australian Centre for Behavioural Research in Diabetes, at Deakin University in Melbourne, discusses the psychological impact of hypoglycemia in people with diabetes. Find more on Medicine Matters diabetes2020-09-0822 min
Fórmula 50s Saúde, Longevidade, EmagrecimentoPré Diabetes tem cura? ✅ O que fazer, comer, dieta para Insulina, Glicemia, Glicose AltaPré diabetes tem cura? Saiba o que fazer e o que pode comer, qual dieta para evitar glicemia alta em jejum, glicose alta, e insulina alta. Uma panorama geral para saber se a pré diabetes tem cura deve ser feito, e essa possibilidade é muito real com aplicações de estratégias de redução de peso e melhora da sensibilidade à insulina. Hoje nesse vídeo vamos ver como a alimentação e outros fatores podem influenciar na resistência à insulina e consequente perda de controle da glicemia, causando glicemia alta, glicose alta e insulina alta, além de hemoglobina glicada alta. I...2020-08-2918 minMedicine Matters diabetesWhy psychosocial care matters: Diabetes distress (with William Polonsky)In this series of podcasts, we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes study group by taking a look at some of the most important and emerging topics within this field. This episode features Professor William Polonsky, from the University of California at San Diego, discussing how diabetes distress affects the wellbeing and glucose management of people with diabetes, and what healthcare professionals can do to help. Find more on Medicine Matters diabetes2020-08-2415 minMedicine Matters diabetesWhy psychosocial care matters: The role of the PSAD (with Frank Snoek)This year is the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes (PSAD) study group. Marking the occasion, the 'Why psychosocial care matters' podcast series will explore important and emerging topics with experts in psychosocial aspects of diabetes. To launch the series, we talk to Professor Frank Snoek, founder and first Chairperson of the study group, about its history and achievements, and the changing profile of psychosocial research in diabetes care. Find more on Medicine Matters diabetes2020-08-2419 min
Strefa Designu Uniwersytetu SWPSProjektowanie jako wspieranie człowieka nowymi technologiami - Martyna MrozekProjektując rozwiązania bazujące na najnowszych technologiach, kierujemy się zasadą Human Centered Design – używamy empatii i stawiamy człowieka w centrum procesu projektowego. Design rozumiemy jako wypadkową psychologii i technologii, jako pomost i wspólny język dla świata nauk ścisłych i humanizmu. Martyna opowie nam, jak wiedza zdobyta na studiach Grafiki Uniwersytetu SWPS łączy się z najnowszymi technologiami i jak wdrażać w życie własne pomysły.
Main event: oblicza projektowania to wydarzenie, które podsumowuje cały rok ciężkiej pracy twórczej studentów Katedry Grafiki Uniwersytetu SWPS. Podczas spotkania udowodniliśmy, że s...2020-06-1608 min
Adis Journal PodcastsEuropean Association for the Study of Diabetes 2019 Conference: Podcast Overview of the ConferenceEASD 2019
Podcast recording of Editorial Board Members Uazman Alam and Shazli Azmi live from the EASD 2019 conference in Barcelona discussing their major take-home messages from the conference. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-019-00714-y. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non...2020-02-1715 minMedicine Matters diabetesHow was it for you? The experts discuss EASD 2019 (with John Wilding, Sanjay Kalra, and Lori Berard)Listen to our clinical advisors discussing their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial. Find more on Medicine Matter diabetes More from EASD 20192019-09-2422 min
Tom Nikkola | VIGOR TrainingGluten Consumption, Babies, and the Risk of Type I DiabetesThere are no good reasons to eat gluten. There are numerous reasons to avoid gluten-containing foods. This includes babies as much as it includes adults.
Yet, parents are often encouraged to give their kids cereal once they start eating whole foods. Perhaps, these findings from The Annual Meeting of the European Association for the Study of Diabetes (EASD) will help you rethink eating it, or at least recommending it for young children.
Based on results of studying more than 80,000 children, researchers in Norway found that gluten consumption at 18 months of age dramatically increased the risk of developing Type I diabetes.
...2019-09-2006 min
Diabetes Austria7 - EASD 2019 - Die Zukunft von CGM und PumpenInterviews mit:
Dr. Francine R. Kaufman, Childrens Hospital Los Angeles
Mirasol Panlilio, Vizepräsidentin Senseonics
Ute Volkmann, Roche2019-09-2000 minDiabetes Austria6 - EASD 2019 - Interview mit Dr. Christian TatschlMediziner und Präsident von big5health, Verein für Gesundheitskompetenz und Lebensfreude2019-09-1900 minDiabetes Austria5 - EASD 2019 - Interview mit Univ.-Prof. Dr.med.univ. Thomas PieberSGLT-2-Hemmer auch für Typ-1-Patienten2019-09-1800 minDiabetes Austria4 - EASD 2019 - Interview mit Prim. Dr. Christian SchelkshornErfolgsstory der SGLT-2-Hemmer: Herz- und Nierenschutz2019-09-1800 minDiabetes Austria3 - EASD 2019 - Interview mit Christian Fexa/ Chefredakteur JatrosEASD 2019 - Christian Fexa2019-09-1700 minDiabetes Austria2 - Eröffnung Europäischer Kongress zur Erforschung von DiabetesEASD 2019 - Eröffnung2019-09-1700 min
Louisville Lectures Internal Medicine Lecture Series PodcastNovel Therapies in Diabetes with Dr. KrishnasamyIn this case-based lecture, Dr. Krishansamy walks through several real-life examples of patients and their indications for novel treatments for diabetes with a focus on mechanisms of action. Included in this lecture is an overview and update on the American Diabetes Association (ADA) guidelines and European Association for the Study of Diabetes (EASD). Finally, she takes a look at new technology to treat type one diabetes.2016-05-2200 min![Alap [Tilos Rádió podcast]](http://mistressofthehearth.files.wordpress.com/2013/05/krishna-lifting-govardhan.jpg)
Alap [Tilos Rádió podcast]Hare KrisnaTermészetesen nem vallásól lesz szó az adásban, hanem olyan szerelmes rágákat hallgatunk meg, amik még közép-kelt-nyugat-Európában is megdobogtatják a hallgatók szívét. Mi köze ennek Krisnához? Ő a szerelmes archetípusa Indiában!Raj Khushi Ram - PakhawajChautal soloLive at Dhrupad Mela 2004.02.16.Amjad Ali Khan - SarodSamta Prasad - TablaRaga RageshwariEMI EASD 1405Amjad Ali Khan - SarodSamta Prasad - TablaRaga Bihari2014-09-141h 57![Alap [Tilos Rádió podcast]](http://i1.ytimg.com/vi/Bcn8vHxfXTc/hqdefault.jpg)
Alap [Tilos Rádió podcast]Ahmed Jan ThirakwaAhmed Jan Thirakwa - TablaAmir Hussain Khan - TablaTabla solo in Teen TalaEASD 1335PLAY: http://tilos.hu/mp3/tilos-20140713-113608-134500.mp3 Ahmed Jan Thirakwa info: http://en.wikipedia.org/wiki/Ahmed_Jan_ThirakwaAli Akbar Khan - SarodSwapan Chaudhury - TablaRaga AlamguiriPLAY: http://tilos.hu/mp3/tilos-20140713-114602-134500.mp3Raga Jogiy-KalengraPLAY...2014-07-131h 58
DiabSite Diabetes-RadioEin niedergelassener Diabetologe auf dem EASD-Kongress Anfang Oktober 2012 fand in Berlin die 48. Jahrestagung der Europäischen Diabetes Gesellschaft (EASD) statt. Warum besucht ein niedergelassener Diabetologe, der Neues auch aus Fachzeitschriften erfährt, diesen internationalen Kongress? Bringt er ihm dennoch neue Erkenntnisse? Gibt es für einen engagierten Diabetes-Spezialisten vielleicht noch ganz andere Gründe für den Kongressbesuch? Den Fragen von DiabSite-Redakteurin Helga Uphoff stellte sich Dr. med. Gregor Hess, niedergelassener Diabetologe DDG mit Schwerpunktpraxis in Worms.
2012-11-0606 minDiabSite Diabetes-RadioHighlights des Europäischen Diabetes-Kongresses 2012 DiabSite-Initiatorin Helga Uphoff war für Sie auf der 48. Jahrestagung der European Association for the Study of Diabetes EASD in Berlin. Vom 1. bis zum 5. Oktober 2012 bot dieser große Europäische Diabetes-Kongress viel Neues, das im Rahmen von zahlreichen Symposien, freien Vorträgen und Postern vorgestellt wurde. Über ein neues Positionspapier; den Wirkstoff Metformin, der auch vor Krebs schützen soll; die Messgenauigkeit von Blutzuckermessgeräten und Insulinpumpen sowie weitere Neuigkeiten vom Kongress sprach Helga Uphoff mit dem Tagungspräsidenten, Prof. Dr. med. Andreas F.H. Pfeiffer.
2012-10-2812 min